» Articles » PMID: 23084518

MDM2 Inhibition in Liposarcoma: a Step in the Right Direction

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2012 Oct 23
PMID 23084518
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

A Rare Case of Dedifferentiated Retroperitoneal Liposarcoma Presenting As Cardiac-Sounding Chest Pain.

Manku B, Addingadoo P, Ali A Cureus. 2021; 13(11):e19503.

PMID: 34790501 PMC: 8589002. DOI: 10.7759/cureus.19503.


Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.

Cherif H, Bisson D, Mannarino M, Rabau O, Ouellet J, Haglund L Elife. 2020; 9.

PMID: 32821059 PMC: 7442487. DOI: 10.7554/eLife.54693.


Soft Tissue Special Issue: Selected Topics in the Pathology of Adipocytic Tumors.

Shon W, Billings S Head Neck Pathol. 2020; 14(1):1-11.

PMID: 31950475 PMC: 7021849. DOI: 10.1007/s12105-019-01112-3.


Epigenetic therapy for ovarian cancer: promise and progress.

Moufarrij S, Dandapani M, Arthofer E, Gomez S, Srivastava A, Lopez-Acevedo M Clin Epigenetics. 2019; 11(1):7.

PMID: 30646939 PMC: 6334391. DOI: 10.1186/s13148-018-0602-0.


SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.

Bill K, Garnett J, Meaux I, Ma X, Creighton C, Bolshakov S Clin Cancer Res. 2015; 22(5):1150-60.

PMID: 26475335 PMC: 4775372. DOI: 10.1158/1078-0432.CCR-15-1522.